Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNSI-Fe Intratumoral Injection in Advanced Solid Tumors
NCT07433283Phase 2Recruiting
- Sponsor
- Sichuan Enray Pharmaceutical Sciences Company
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of CNSI-Fe(II) in solid tumor, sponsored by Sichuan Enray Pharmaceutical Sciences Company. Started Nov 2024; status: recruiting.
02
Drugs
CNSI-Fe(II)
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07433283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07433283.